<bill session="108" type="s" number="666" updated="2023-01-15T23:03:28Z">
  <state datetime="2003-03-19">REFERRED</state>
  <status>
    <introduced datetime="2003-03-19"/>
  </status>
  <introduced datetime="2003-03-19"/>
  <titles>
    <title type="display">Biological, Chemical, and Radiological Weapons Countermeasures Research Act</title>
    <title type="official" as="introduced">A bill to provide incentives to increase research by private sector entities to develop antivirals, antibiotics and other drugs, vaccines, microbicides, detection, and diagnostic technologies to prevent and treat illnesses associated with a biological, chemical, or radiological weapons attack.</title>
    <title type="short" as="introduced">Biological, Chemical, and Radiological Weapons Countermeasures Research Act</title>
    <title type="short" as="introduced" partial="1">Biological, Chemical, and Radiological Weapons Countermeasures Research Act of 2003</title>
  </titles>
  <sponsor bioguide_id="L000304"/>
  <cosponsors>
    <cosponsor bioguide_id="H000338" joined="2003-03-19"/>
  </cosponsors>
  <actions>
    <action datetime="2003-03-19">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2003-03-19">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S4009-4017"/>
    </action>
    <action datetime="2003-03-19" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
    <action datetime="2004-10-06">
      <text>Committees on Health, Education, Labor, and Pensions; the Judiciary. Hearings held.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Hearings"/>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Animal diseases"/>
    <term name="Animals"/>
    <term name="Antibiotics"/>
    <term name="Antitrust law"/>
    <term name="Armed Forces and National Security"/>
    <term name="Arsenic"/>
    <term name="Biochemistry"/>
    <term name="Biological warfare"/>
    <term name="Biotechnology"/>
    <term name="Blood diseases"/>
    <term name="Business records"/>
    <term name="Capital investments"/>
    <term name="Cardiovascular diseases"/>
    <term name="Chemical warfare"/>
    <term name="Cholera"/>
    <term name="Civil Rights and Liberties, Minority Issues"/>
    <term name="Clinical trials"/>
    <term name="Colleges"/>
    <term name="Commerce"/>
    <term name="Communicable diseases"/>
    <term name="Conferences"/>
    <term name="Confidential communications"/>
    <term name="Congress"/>
    <term name="Congressional oversight"/>
    <term name="Congressional reporting requirements"/>
    <term name="Corporation taxes"/>
    <term name="Department of Health and Human Services"/>
    <term name="Diseases"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="EBB Terrorism"/>
    <term name="Economics and Public Finance"/>
    <term name="Emergency Management"/>
    <term name="Environmentally induced diseases"/>
    <term name="Epidemics"/>
    <term name="Equipment and supplies"/>
    <term name="Federal aid to education"/>
    <term name="Federal aid to health facilities"/>
    <term name="Federal aid to research"/>
    <term name="Federal-state relations"/>
    <term name="Finance and Financial Sector"/>
    <term name="Genetics"/>
    <term name="Government Operations and Politics"/>
    <term name="Government procurement"/>
    <term name="Government trust funds"/>
    <term name="Governmental investigations"/>
    <term name="Grants-in-aid"/>
    <term name="Heavy metals"/>
    <term name="Higher education"/>
    <term name="Hospitals"/>
    <term name="Immunology and vaccination"/>
    <term name="Income tax"/>
    <term name="Indemnity"/>
    <term name="Industrial buildings"/>
    <term name="Industrial management"/>
    <term name="Intellectual property"/>
    <term name="International Affairs"/>
    <term name="International cooperation"/>
    <term name="Investment tax credit"/>
    <term name="Laboratories"/>
    <term name="Laboratory animals"/>
    <term name="Law"/>
    <term name="Lead"/>
    <term name="Liability (Law)"/>
    <term name="License agreements"/>
    <term name="Malaria"/>
    <term name="Medical innovations"/>
    <term name="Medical screening"/>
    <term name="Medical statistics"/>
    <term name="Medical supplies"/>
    <term name="Medical technology"/>
    <term name="Medical tests"/>
    <term name="Mercury"/>
    <term name="Microbiology"/>
    <term name="Nervous system diseases"/>
    <term name="Nonprofit organizations"/>
    <term name="Nosocomial infections"/>
    <term name="Nuclear terrorism"/>
    <term name="Orphan drugs"/>
    <term name="Partnerships"/>
    <term name="Patents"/>
    <term name="Pharmaceutical research"/>
    <term name="Plague"/>
    <term name="Public Lands and Natural Resources"/>
    <term name="Quality control"/>
    <term name="Radiation"/>
    <term name="Radiation safety"/>
    <term name="Radioactive pollution"/>
    <term name="Research and development"/>
    <term name="Research and development tax credit"/>
    <term name="Respiratory diseases"/>
    <term name="Right of privacy"/>
    <term name="Salmonella"/>
    <term name="Science, Technology, Communications"/>
    <term name="Security measures"/>
    <term name="Skin diseases"/>
    <term name="Social Welfare"/>
    <term name="Tax credits"/>
    <term name="Tax exclusion"/>
    <term name="Tax incentives"/>
    <term name="Taxation"/>
    <term name="Technological innovations"/>
    <term name="Technology transfer"/>
    <term name="Terrorism"/>
    <term name="Typhoid fever"/>
    <term name="Vaccination"/>
    <term name="Vaccines"/>
    <term name="Victims of terrorism"/>
    <term name="Virus diseases"/>
    <term name="Weapons of mass destruction"/>
    <term name="Yellow fever"/>
    <term name="Zoning and zoning law"/>
  </subjects>
  <amendments/>
  <summary date="2006-11-28T17:35:40Z" status="Introduced in Senate">Biological, Chemical, and Radiological Weapons Countermeasures Research Act - Amends the Homeland Security Act of 2002 to add a new title, Title 18: Biological, Chemical, and Radiological Countermeasures Research, which may be cited as the Biological, Chemical, and Radiological Weapons Countermeasures Research Act of 2003.Directs the Secretary of Homeland Security to make available to manufacturers of terror weapons countermeasures, and to publish, a list of materials that may be used as weapons of mass destruction (WMD). Directs the Secretary to revise the list on at least an annual basis. Requires the Secretary to determine countermeasures that diagnose, treat, or prevent infection from biological agents or toxins (countermeasures) for each item on the list.Requires private sector entities that are engaged in certain research to register with the Department of Homeland Security if they wish to benefit from various tax, patent, procurement, liability limitations, and other incentives established under this Act. Classifies such research as: (1) countermeasures; (2) equipment to detect a terrorist attack carried out with a terror weapon (detection equipment); (3) diagnostics to detect, identify, or analyze biological agents or toxins (diagnostics); and (4) research tools used in the laboratory (research tools) that enable the rapid and effective development of countermeasures.Establishes in the Treasury of the United States a "Terror Weapon Countermeasure Purchase Fund (TWCPF)" to purchase, and provide adequate payment for, countermeasures, detection equipment, diagnostics, and research tools.Extends market exclusivity for new drugs that are countermeasures.Authorizes the Director of the National Institutes of Health (NIH) to award partnership challenge grants to promote joint ventures between NIH, its grantees, and for-profit biotechnology, pharmaceutical, and medical device industries for the development of countermeasures and research tools.</summary>
</bill>
